T9	Exp 46 50	that
T10	Exp 66 91	the regulatory P sequence
T11	Exp 115 143	the human interleukin-4 gene
T12	Exp 239 244	which
T13	Exp 184 198	The P sequence
T14	Exp 202 225	the human interleukin-4
T15	Exp 399 413	the NF-kappa B
T16	Exp 418 435	the NF-AT binding
T17	Exp 443 445	We
T18	Exp 500 514	the P sequence
T19	Exp 715 719	when
T20	Exp 601 615	the P sequence
T21	Exp 700 714	the P sequence
T22	Exp 976 980	that
T23	Exp 860 892	the unlabeled NF-AT binding site
T24	Exp 904 934	the unlabeled AP1 binding site
T25	Exp 990 1004	the P sequence
T26	Exp 1194 1198	that
T27	Exp 1199 1212	the component
T28	Exp 1229 1261	the potential to reconstitute NF
T29	Exp 1171 1184	These results
T30	Exp 1378 1403	its DNA binding component
R5	Coref Anaphora:T9 Antecedent:T31
R6	Coref Anaphora:T12 Antecedent:T32
R7	Coref Anaphora:T22 Antecedent:T33
R8	Coref Anaphora:T30 Antecedent:T7
T1	Protein 125 138	interleukin-4
T2	Protein 212 225	interleukin-4
T3	Protein 227 231	IL-4
T4	Protein 564 567	P65
T5	Protein 571 574	P65
T6	Protein 575 578	P50
T7	Protein 1118 1121	P65
T31	Exp 39 45	factor
T32	Exp 233 237	gene
T33	Exp 964 975	an activity
